Personalis Investor Relations Material
Latest events
Q1 2025
Personalis
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Personalis Inc
Access all reports
Segment Data
Access more data
Revenue by
Customer type
Pharma tests and services
Enterprise sales
Population sequencing
Other
Expenses by
Financials
Personalis Cancer Genome Tests allow physicians to classify patients' tumors based on shared genomic changes and match them with therapies known to be effective for those alterations, such as targeted therapies, immunotherapies, or clinical trials. Its software solutions include ACE Clinical that provides clinical researchers with data-driven insights into biomarkers and biologic drug mechanisms; ACE Biology that interprets human genome information to allow researchers to gain insight into potential oncology drug targets and underlying mechanisms of drug resistance; and Product Management platform that allows customers to order personalized tests. The company was formerly known as Illumina TRUseq Custom Amplicon and changed its name to Personalis, Inc. in May 2013. Personalis, Inc. was founded in 2012 and is headquartered in Menlo Park, California.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
PSNL
Country
🇺🇸 United States